(Q34436782)

2 August 2017

Sildenafil therapy in patients with sickle cell disease and pulmonary hypertension (English)

1 reference

2 August 2017

0 references

0 references

1 reference

13

Mark T Gladwin

1 reference

2 August 2017

Christian Hunter

10

0 references

Gregory J. Kato

object named as

Gregory J Kato

3

0 references

Robyn J Barst

4

object named as

Robyn J Barst

1 reference

2 August 2017

Roberto F Machado

1

1 reference

2 August 2017

Sabrina Martyr

2

1 reference

2 August 2017

Anastasia Anthi

5

1 reference

2 August 2017

Michael R Robinson

6

1 reference

2 August 2017

Lori Hunter

7

1 reference

2 August 2017

Wynona Coles

8

1 reference

2 August 2017

James Nichols

9

1 reference

2 August 2017

Vandana Sachdev

11

1 reference

2 August 2017

Oswaldo Castro

12

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 August 2005

1 reference

British Journal of Haematology

2 August 2017

1 reference

2 August 2017

130

1 reference

2 August 2017

445-453

1 reference

2 August 2017

3

1 reference

Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell disease

2 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063570

Sildenafil for pulmonary hypertension

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063570

Sitaxsentan therapy for pulmonary arterial hypertension

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063570

Oral sildenafil as long-term adjunct therapy to inhaled iloprost in severe pulmonary arterial hypertension

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063570

Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063570

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063570

Plasma brain natriuretic peptide levels increase in proportion to the extent of right ventricular dysfunction in pulmonary hypertension.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063570

Quantitative assessment of pulmonary hypertension in patients with tricuspid regurgitation using continuous wave Doppler ultrasound.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063570

Noninvasive estimation of right atrial pressure from the inspiratory collapse of the inferior vena cava

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063570

Pulmonary hypertension in sickle cell disease: cardiac catheterization results and survival

6 July 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05625.X

Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05625.X

Pulmonary hypertension as a risk factor for death in patients with sickle cell disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05625.X

Long-Term Treatment With Oral Sildenafil Is Safe and Improves Functional Capacity and Hemodynamics in Patients With Pulmonary Arterial Hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05625.X

Arginine therapy: a new treatment for pulmonary hypertension in sickle cell disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05625.X

Evidence for a metabolic shift of arginine metabolism in sickle cell disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05625.X

Brain natriuretic peptide and exercise capacity in lung fibrosis and pulmonary hypertension.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063570

Clinical significance of brain natriuretic peptide in primary pulmonary hypertension.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063570

Sildenafil for long-term treatment of nonoperable chronic thromboembolic pulmonary hypertension

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063570

Plasma brain natriuretic peptide as a prognostic indicator in patients with primary pulmonary hypertension

27 October 2018

1 reference

12 December 2020

Bosentan therapy for pulmonary arterial hypertension

1 reference

12 December 2020

Pulmonary Hypertension as a Risk Factor for Death in Patients with Sickle Cell Disease

1 reference

12 December 2020

Arginase activity in erythrocytes of healthy and ill children

1 reference

12 December 2020

1 reference

12 December 2020

cGMP and cAMP cause pulmonary vasoconstriction in the presence of hemolysate

1 reference

12 December 2020

ENZYMATIC ACTIVITIES OF THE BLOOD SERUM IN THALASSEMIA AND IN THALASSODREPANOCYTOSIS

1 reference

12 December 2020

10.1111/J.1365-2141.2005.05625.X

Identifiers

DOI

1 reference

2 August 2017

1 reference

2 August 2017

1 reference